FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Panel to Discuss Amylin Pharma’s Metreleptin

10/30/2013

Federal Register Notice: FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet 12/11 from 8 a.m. to 5 p.m. a...

Panel to Discuss 2 BLAs for Crohn’s Disease, Colitis

10/30/2013

Federal Register Notice: FDA’s Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Co...

FDA Corrects Notice on Secure Supply Chain Program

09/27/2013

Guidance on Color Additives in Animal Foods

09/27/2013

Federal Register Notice: FDA is making available a guidance for industry 223 entitled Small Entity Compliance Guide — Declar...

Comments Sought on Antimicrobial New Animal Drugs

09/27/2013

Guidance on Electronic Source Data in Clinical Trials

09/18/2013

Federal Register Notice: FDA is making available a guidance for industry entitled Electronic Source Data in Clinical Investigation...

Guidance on Patient Counseling Section for Drug/Biologic Labels

09/18/2013

Public Hearing on Emergency Eye Wash Products

09/18/2013

Federal Register Notice: FDA will hold a public hearing 12/4 on currently marketed OTC emergency first aid eye wash drug products ...

Info on Electronic Labeling for Drugs, Biologics Sent to OMB

09/13/2013

Federal Register Notice: FDA’s proposed collection of information, “Requirements for Submission of Labeling for Human ...

Workshop on Devices to Treat Metabolic Diseases

09/13/2013